Results 211 to 220 of about 4,527 (242)
Some of the next articles are maybe not open access.

Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets

Journal of Controlled Release, 2022
Although in-vivo bioequivalence (BE) study serves as a golden standard for establishing interchangeability of oral dosage forms, it remains challenging for products with high inter-subject variability such as mesalazine enteric-coated tablet to fulfil the BE criteria set by regulatory authorities.
Yufeng, Zhang   +5 more
openaire   +2 more sources

Gastric Retention of Enteric-Coated Magnesium Chloride Tablets

Annals of Pharmacotherapy, 1994
OBJECTIVE: To describe a patient with gastric retention of enteric-coated magnesium chloride tablets. Potential drug and disease etiologies accounting for failure to empty this dosage form are discussed. DESIGN: Single case report. CASE SUMMARY: A seriously ill patient with metastatic small-cell lung cancer accumulated 21 enteric-coated magnesium ...
D J, Chapron, L B, Korman, W L, Barry
openaire   +2 more sources

Dissolution Behavior of Commercial Enteric-coated Aspirin Tablets

Journal of Pharmaceutical Sciences, 1979
Dissolution behavior was studied for four commercial batches of enteric-coated aspirin tablets from two companies. The USP XIX dissolution procedure was modified by including pretreatment in simulated gastric juice. The effects of five pretreatment times were studied.
K, Embil, G, Torosian
openaire   +2 more sources

GLC Determination of Erythromycin in Enteric-coated Tablets

Journal of Pharmaceutical Sciences, 1972
A GLC assay method for erythromycin in tablets is described. This method involves the extraction, silylation, and chromatography of erythromycin from tablets, and it yields an average recovery of 100.6% with a coefficient of variation of about 2%.
J H, Robertson, K, Tsuji
openaire   +2 more sources

Development and Evaluation of Enteric-Coated Penicillamine Tablets

Journal of Pharmaceutical Sciences, 1984
Commercially available 250-mg penicillamine tablets were converted into enteric-coated tablets. Based on in vitro dissolution and disintegration tests, tablets coated with five layers of a cellulose acetate phthalate formulation by a modified pan coating technique were judged to be superior to other coated tablets. These tablets resisted disintegration
W G, Chambliss   +5 more
openaire   +2 more sources

Crushed Enteric-Coated Methenamine Tablets

JAMA: The Journal of the American Medical Association, 1973
To the Editor.— The authors of the article, "Lipoid Pneumonia Caused By Methenamine Mandelate Suspension" (225:1524, 1973), concluded that "Simply, methenamine tablets can be crushed and given with food to problem patients." Methenamine mandelate (Mandelamine) is available as an entericcoated tablet (0.25, 0.5, 1.0 gm).
openaire   +1 more source

Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets

European Journal of Gastroenterology & Hepatology, 2001
A patient who presented with upper abdominal pain, nausea and ascites together with peripheral eosinophilia is described. Based on a surgical full-thickness biopsy of the antrum, the diagnosis of eosinophilic gastroenteritis was made. Treatment with prednisone resulted in a clinical response, but the prednisone dose could not be lowered below 5 mg.
Tan, A., Kruimel, J.W., Naber, A.H.J.
openaire   +3 more sources

Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections

International Journal of Pharmaceutics, 2021
Intestinal Pseudomonas aeruginosa is highly problematic in immunocompromised patients such as those in intensive care units in hospitals. Phage therapy is an attractive alternative or supplementary therapy to antibiotics as it not only kills multidrug-resistant bacteria, but also minimises the disruption of gut microflora. Solid oral dosage forms (i.e.,
Dipesh, Khanal   +4 more
openaire   +2 more sources

Tableting and stability evaluation of enteric-coated omeprazole pellets

European Journal of Pharmaceutics and Biopharmaceutics, 2004
In this study, fluidized-bed manufactured enteric-coated omeprazole pellets were compressed into tablets. The stability of the pellets and those of compressed tablets were evaluated for remaining omeprazole and for degradation products under an accelerated stability protocol. The data were analyzed using the artificial neural network (ANN) and analysis
Murat, Türkoğlu   +2 more
openaire   +2 more sources

Gastric retention of enteric‐coated aspirin tablets in beagle dogs

Journal of Veterinary Pharmacology and Therapeutics, 1990
Nap, R.C., Breen, D.J., Lam, T.J.G.M. & de Bruyne, J.J. Gastric retention of enteric‐coated aspirin tablets in beagle dogs. J. vet. Pharmacol. Therap. 13, 148–153.Administration of acetylsalicyclic acid (ASA) in the dog may cause gastric mucosal damage. Enteric‐coated tablets protect the canine stomach during oral ASA medication.
Nap, R C   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy